MED12 and uterine corpus leiomyoma: It has been shown that three main uterine leiomyoma molecular subtypes exist, including tumors with MED12 mutation, molecular aberrations leading to HMGA2 overexpression, and biallelic loss of FH [8, 10, 11, 20–23].